November 2017

As the federal deadline for cannabis legalization draws nearer, work done by O’Brien Institute for Public Health researchers is lighting the way for policymakers in Alberta, and across the country. When the Alberta government went out looking for evidence — cold, hard facts about marijuana that could inform a made-in-Alberta strategy with respect to federal legalization […]

by

Adolescent cannabis use is an independent risk factor for future hypomania – often experienced as part of bipolar disorder – finds new research led by University of Warwick First research to robustly test the association between adolescent cannabis use and hypomania (periods of elated mood, over-active and excited behaviour, reduced need for sleep) in early […]

by

Research grant will support the development of novel dosage forms and clinical studies NANAIMO, BC, Nov. 30, 2017 /CNW/ - Tilray, a global leader in medical cannabis research and production, today announced that the company has received research grant from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) to support product development and […]

by

While the launch of the legalized cannabis industry in California is just one month away, the risks and health hazards that its workers will face are remain largely unstudied, according to a UC Davis health professor. Speaking to an audience of about 50 people gathered in Humboldt State University’s Goodwin Forum on Thursday evening, UC […]

by

ST. PAUL, Minn. – Minnesota health officials say they’re adding autism spectrum disorders and obstructive sleep apnea as conditions that qualify for medical marijuana. Health Commissioner Ed Ehlinger says there is increasing evidence that medical marijuana can help people with severe autism or obstructive apnea. “Any policy decisions about cannabis are difficult due to the […]

by

LOS ANGELES, Nov. 30, 2017 /PRNewswire/ – It is a pivotal time in the cannabis industry, especially in California. Recreational marijuana will be legal on January 1, 2018, and all consumer cannabis products will need to pass rigorous mandatory laboratory testing requirements. CERESLabs, who opened their doors to the investment community this week, plans to capitalize […]

by

TORONTO, Nov. 29, 2017 (GLOBE NEWSWIRE) — Resolve Digital Health Inc. (“Resolve”), a Canadian developer of intelligent medical cannabis delivery devices, has begun protocol design for a series of studies examining the safety and efficacy profiles of Resolve medical cannabis formulations compared to commonly-prescribed oxycodone-based prescription drugs such as OxyContin®/OxyNEO® and Percocet®. Resolve is designing […]

by

Research grant will support the development of novel dosage forms and clinical studies NANAIMO, BC, Nov. 30, 2017 /CNW/ - Tilray, a global leader in medical cannabis research and production, today announced that the company has received research grant from the National Research Council of Canada Industrial Research Assistance Program (NRC-IRAP) to support product development and […]

by

With cannabis set to become legal for recreational use in July 2018 in Canada, and usage of the product for medical purposes steadily rising both in Canada and worldwide, cannabis companies have ramped up their efforts to make new scientific discoveries related to the plant’s medical uses. Companies leading the quest to demonstrate the potential […]

by

Austin mother Katie Graham plays a delicate balancing act. Her 7-year-old son Elliot struggles with a severe form of epilepsy, known as Lennox-Gastaut syndrome. He’s tried various medications, including drug trials, over the years to quell its symptoms. “It’s like having lightning storms in your brain several times a day,” Graham said of her youngest […]

by

Dravet syndrome is a serious form of childhood epilepsy that first shows up in babies at six to nine months old, resulting in cognitive impairments, autistic-like behaviors, and premature death.  About 15 percent of children with Dravet syndrome die before they reach the age of 13, according to William Catterall, a lead researcher, professor, and […]

by